English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduSubstances present in cooked meats are associated with increased wheezing in children
Tag: Icahn School of Medicine at Mount Sinai
Royalty Pharma Donates $1,000,000 To Support Mount Sinai’s COVID-19 Patient Care and Clinical Research
Royalty Pharma today announced a charitable contribution by Royalty Pharma in the amount of $1,000,000 to Mount Sinai Health System.
Social media and smartphone app use predicts maintenance of physical activity during Covid-19
Co-corresponding Authors: M. Mercedes Perez-Rodriguez, MD, PhD, Assistant Professor of Psychiatry and Agnes Norbury, PhD, Post Doctoral Fellow, both of the Icahn School of Medicine at Mount Sinai Bottom Line: During lockdowns (stay-at-home orders issued in response to the Covid-19…
Artificial Intelligence Algorithm Can Predict Outcomes of COVID-19 Patients With Mild Symptoms in Emergency Rooms
Technology may lead to quicker triage and treatment based on patient data and scans
Majority of Pregnant Women Who Tested Positive for COVID-19 Were Asymptomatic, Study Finds
The majority of pregnant women who tested positive for COVID-19 on arrival to the delivery room were asymptomatic, according to a new paper by Mount Sinai researchers.
Mount Sinai Researchers Advance a Universal Influenza Virus Vaccine
A vaccine that induces immune responses to a wide spectrum of influenza virus strains and subtypes has produced strong and durable results in early-stage clinical trials in humans, Mount Sinai researchers have found.
Go Inside the Most Innovative Minds in Science and Medicine on “Real, Smart People,” a New Podcast
Podcast from the Icahn School of Medicine at Mount Sinai offers a glimpse into the real story of how science and medicine moves forward, one smart person at a time.
Three Mount Sinai Ophthalmologists Receive Prestigious Achievement Awards
Multiple honors recognize leadership and exemplary scientific and educational contributions
Potential New Therapies for Alzheimer’s Disease are Revealed through Network Modeling of Its Complex Molecular Interactions
Researchers from Mount Sinai and the National Center for Geriatrics and Gerontology in Japan have identified new molecular mechanisms driving late-onset Alzheimer’s Disease.
Arnhold Institute for Global Health to Host Mount Sinai World AIDS Day
The Arnhold Institute for Global Health at the Icahn School of Medicine Mount Sinai will host a virtual event on World AIDS Day.
Mount Sinai Health System Joins Thousands of Top U.S. Hospitals Encourage Everyone to #MaskUp
Growing numbers of COVID-19 cases and deaths are troubling; facemasks can slow the trend
Mount Sinai Cardiologist Awarded $2.9 Million NIH Grant to Advance Work with Stem Cells and Heart Repair after Heart Attack
Research may lead to identifying novel therapies for cardiac patients
Mount Sinai Heart Awarded Transcatheter Valve Certification by American College of Cardiology
Only program in New York City to receive prestigious recognition
A Novel Monoclonal Antibody Therapy Cuts LDL Cholesterol by Half in a High-Risk Patient Population, Study Shows
The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol—the so-called “bad” cholesterol—by 50 percent in patients with severe hypercholesterolemia whose condition is resistant to standard treatments, a phase 2 study from the Icahn School of Medicine of Mount Sinai and other global academic sites has found.
Diabetes Drug Can Treat and Reverse Heart Failure and Reduce Hospitalizations
Mount Sinai clinical trial results could help lead to FDA approval
New Insights Into Facial Birth Defects Are Revealed by Mount Sinai Researchers
Mount Sinai researchers have revealed new insights into how the body regulates craniofacial development in newborns, which can sometimes lead to birth defects such as cleft lip or palate.
What We Know: Mount Sinai to Host COVID-19 Research Symposium
The COVID-19 Research Symposium, hosted by the Mount Sinai Clinical Intelligence Center (MSCIC), is a one-day comprehensive review of advances in research by the Mount Sinai Health System to better understand and treat the coronavirus known as COVID-19.
Mount Sinai’s Valentin Fuster, MD, PhD, Honored by Thai Royal Family for Outstanding Medical Contributions
Thailand’s Royal Family has named Valentin Fuster, MD, PhD, Director of Mount Sinai Heart and Physician-in-Chief of The Mount Sinai Hospital, a winner of the 29th annual Prince Mahidol Award in the field of Medicine.
Study of Nearly 2,000 Marine Recruits Reveals Asymptomatic SARS-CoV-2 Transmission Among Young Adults During Supervised Quarantine
Results suggest the need for widespread surveillance testing to reduce COVID-19 transmission in group settings
Mount Sinai Develops Machine Learning Models to Predict Critical Illness and Mortality in COVID-19 Patients
Mount Sinai researchers have developed machine learning models that predict the likelihood of critical events and mortality in COVID-19 patients within clinically relevant time windows.
Study Finds 1.7 Million New Yorkers Have Been infected with SARS-Cov-2 and Virus was in NYC Earlier than Reported
The virus that causes COVID-19 was present in New York City long before the city’s first case of the disease was confirmed on March 1
Most People Mount a Strong Antibody Response to SARS-CoV-2 That Does Not Decline Rapidly
The vast majority of individuals infected with mild-to-moderate COVID 19 mount a robust antibody response that is relatively stable for at least five months, according to research conducted at the Icahn School of Medicine at Mount Sinai and published October 28, in the journal Science.
Mount Sinai Receives $4 Million Gift to Support Prostate Health and Urology Department
Mount Sinai has received a $4 million donation from Lizzie and Jonathan Tisch to support prostate health and the Milton and Carroll Petrie Department of Urology at Mount Sinai.
Mount Sinai Researchers Develop a First-in-Class Humanized Antibody Targeting Bone and Fat
Blocking the Follicle-Stimulating Hormone (FSH) whose levels rise at menopause could solve bone loss and weight gain Senior Author: Mone Zaidi, MD, PhD, MACP, Director of the Mount Sinai Bone Program and Professor of Medicine (Endocrinology, Diabetes and Bone Disease) at…
Ultrasounds Show Impact of COVID-19 on the Heart
International study may guide therapeutic strategies in patients with and without underlying heart conditions
Mount Sinai Doctors Elected to National Academy of Medicine for Contributions to Emergency Medicine and Translational Genetics
Brendan G. Carr, MD, MA, MS, and Judy H. Cho, MD, of the Icahn School of Medicine at Mount Sinai, have been elected to the National Academy of Medicine (NAM).
Mount Sinai Study Shows Novel Surgical Technique For Prostate Cancer Improves Urinary Continence
Mount Sinai study described a novel surgical technique, the RARP “hood technique” which showed a reduction in postoperative urinary incontinence and facilitated early return of continence in patients with localized prostate cancer.
Mount Sinai Researchers Find That Where People Live Can Impact Their Risk for Common Chronic Conditions Including High Blood Pressure and Depression
The researchers found that a persons’ place of residence substantially influences their risk of uncontrolled chronic disease including high blood pressure and depression
Mount Sinai Health System, Healthcare Association of New York State and Hospital Innovation and Lean Network of New York to Host Conference: “Lean and Innovation in a COVID-19 World”
Virtual conference will highlight Lean innovations that have helped healthcare organizations plan for, manage and mitigate many aspects of the COVID-19 pandemic
Thomas J. Fuchs, DSc, Named Dean of Artificial Intelligence and Human Health and Co-Director of the Hasso Plattner Institute for Digital Health at Mount Sinai
Appointment Advances Health System’s Role as Leader in AI and Digital Health
The Novel Role of Microglia as Modulators of Neurons in the Brain Is Discovered by Mount Sinai Researchers
Findings offer potential target for treating behavioral abnormalities associated with neurodegenerative conditions like Alzheimer’s Disease
New York State Department of Health Grants Emergency Use Authorization to Mount Sinai for Quantitative COVID-19 Antibody Test
The Clinical Laboratories of The Mount Sinai Hospital has received emergency use authorization from the New York State Department of Health (NYSDOH) for quantitative use of Mount Sinai’s COVID-19 antibody test, making Mount Sinai’s lab the first in the country to run an authorized, fully quantitative antibody test that can deliver a precise numeric measurement of the level of antibodies in a patient’s blood
HealthQuarters and Mount Sinai Health System Promise to Deliver Curated, Comprehensive Health and Wellness Experience
HealthQuarters today announces a new venture with Mount Sinai Health System to expand access to world-class health care services.
MEDIA ADVISORY- Back to School, Cold & Flu Season and COVID-19 – What do you do if you get sick?
Mount Sinai experts say get your flu shot early and have a plan for point-of-care
Mount Sinai Health System Hospitals Receive Top Quality Achievement Awards for Stroke and Cardiac Care
Mount Sinai Health System Hospitals Receive Top Quality Achievement Awards for Stroke and Cardiac Care
Mount Sinai Serves as Official Medical Services Provider and Advisor on COVID-19 Safety for Athletes at 2020 US Open
Mount Sinai will serve as the official medical services provider for the eighth consecutive year at the US Open
Researchers Discover a Specific Brain Circuit Damaged by Social Isolation During Childhood
Study shows long-lasting effects and points the way to potential treatments
Mount Sinai Team Offers Additional Data on Efficacy of Blood Thinners for COVID-19 and Insight on Best Potential Regimens
Study is the basis of a new international clinical trial
Mount Sinai Study Finds COVID Patients Were Most Commonly Readmitted to Hospital for Respiratory Complications
Study describes characteristics of patients with COVID-19 who returned to the ER or required readmission to the hospital within 14 days of being discharged
Dilated Blood Vessels in the Lung May Explain Low Oxygen Levels in Severe Cases of COVID-19
A new pilot study from the Icahn School of Medicine at Mount Sinai suggests that COVID-19 is causing significant dilation of the blood vessels of the lung, specifically the capillaries.
New Study Identifies Better Treatment Option for Common Complication of Dialysis
Use of drug-coated balloon angioplasty to treat blocked blood vessels used for hemodialysis offers hope for millions of patients globally
New York Eye and Ear Infirmary of Mount Sinai Celebrates 200th Anniversary and Honors its Pioneering Black Physician
Hosts Dedication for a Former Slave Who Became Country’s First African American Eye and Ear Specialist
Mount Sinai’s Arnhold Institute for Global Health Partners with NYC Health + Hospitals on COVID-19 Unit for Research at Elmhurst (CURE-19)
Collaboration Brings Together Clinicians and Researchers on the Front Lines of COVID-19 to Support Innovative Solutions for Health Disparities
Epigenetic Changes in ADNP Syndrome, a Cause of Autism, Do Not Indicate Profound Presentation of the Disorder
A study led by the Seaver Autism Center for Research and Treatment at Mount Sinai found that two different blood epigenetic signatures associated with ADNP syndrome (also known as Helsmoortel-Van Der Aa syndrome) have only a modest correlation with clinical manifestations of the syndrome.
Mount Sinai Researchers Discover Treatment Option for Rare Genetic Disorder
Researchers from the Icahn School of Medicine used a novel genetic sequencing technology to identify the genetic cause of—and a treatment for—a previously unknown severe auto inflammatory syndrome affecting an 18-year-old girl since infancy.
The Mount Sinai Hospital Ranked Among Top in the Nation by U.S. News & World Report; Brookdale Department of Geriatrics and Palliative Medicine Claims No. 1 Spot in Specialty Rankings
The Mount Sinai Hospital, the flagship hospital of Mount Sinai Health System, was listed among the nation’s top hospitals for care excellence in U.S. News and World Report, marking the fifth straight year the hospital has been listed among the top 20 in the country while landing on the distinctive “Honor Roll” list.
SARS-CoV-2 is More Severe in Men, Emerging Data Suggests in New Review by Mount Sinai Researchers
Senior Author: Ash Tewari, MBBS, MCh, Chair of the Department of Urology at the Mount Sinai Health System, Professor, Urology, Oncological Sciences, Icahn School of Medicine at Mount Sinai First Author: Dimple Chakravarty, PhD, Assistant Professor, Urology, Icahn School of Medicine…
Mount Sinai Researcher Identifies Single Gene Biomarker to Differentiate Between Atopic Dermatitis and Psoriasis Using Adhesive Tape Strips
Mount Sinai researchers have pinpointed a single gene biomarker, nitride oxide synthase 2 (NOS2) that can distinguish atopic dermatitis (AD) and psoriasis with 100 percent accuracy using adhesive tape strips, a non-invasive alternative to skin biopsy. The research will be published online today in the Journal of Allergy and Clinical Immunology.
Mount Sinai study finds SARS-CoV-2 induces robust antibody responses stable for at least 3 months
Research from the Mount Sinai Health System, just posted to pre-print server MedRxiv (https://www.medrxiv.org/content/10.1101/2020.07.14.20151126v1), shows that the vast majority (more than 90%) of infected individuals with mild-to-moderate COVID 19 experience robust IgG antibody responses against the viral spike protein. The researchers also show…
Low-Carbohydrate Diet May Be Associated With Lower Risk of Blinding Eye Disease
Following a long-term diet that’s low in carbohydrates and high in fat and protein from vegetables may lower the risk of the most common subtype of glaucoma